Resources

Type of publications
Regions
Diseases
5113 results found
2022 ∙ Li, M. Wang, X. Feng, J. Feng, Z. Li, W. Ya, B.
Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
Adolescents COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Goyal, M. Ray, I. Mascarenhas, D. Kunal, S. Sachdeva, R. A. Ish, P.
Myocarditis post-SARS-CoV-2 vaccination: A systematic review
Adolescents Adults Older adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yasuhara, J. Masuda, K. Aikawa, T. Shirasu, T. Takagi, H. Lee, S. Kuno, T.
Myopericarditis After COVID-19 mRNA Vaccination Among Adolescents and Young Adults: A Systematic Review and Meta-analysis
Adolescents COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ling, Ryan Ruiyang Ramanathan, Kollengode Tan, Felicia Liying Tai, Bee Choo Somani, Jyoti Fisher, Dale MacLaren, Graeme
Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Pittet, L. F. Thøstesen, L. M. Aaby, P. Kofoed, P. E. Curtis, N. Benn, C. S.
Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis
Newborn Tuberculosis Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cancarevic, I. Nassar, M. Medina, L. Sanchez, A. Parikh, A. Hosna, A. Devanabanda, B. Vest, M. Ayotunde, F. Ghallab, M. Omran, I.
Nephrotic Syndrome in Adult Patients With COVID-19 Infection or Post COVID-19 Vaccine: A Systematic Review
Adults Older adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lotan, I. Lydston, M. Levy, M.
Neuro-Ophthalmological Complications of the COVID-19 Vaccines: A Systematic Review
Adults Older adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Alonso Castillo, R. Martínez Castrillo, J. C.
Neurological manifestations associated with COVID-19 vaccine
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cheng, H. Peng, Z. Si, S. Alifu, X. Zhou, H. Chi, P. Zhuang, Y. Mo, M. Yu, Y.
Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
Adults Older adults COVID-19 Administration Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, X. Chen, Z. Azman, A. S. Sun, R. Lu, W. Zheng, N. Zhou, J. Wu, Q. Deng, X. Zhao, Z. Chen, X. Ge, S. Yang, J. Leung, D. T. Yu, H.
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...